• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Option Care Health Inc. (Amendment)

    2/14/23 12:37:57 PM ET
    $OPCH
    Medical/Nursing Services
    Health Care
    Get the next $OPCH alert in real time by email
    SC 13G/A 1 opch13gadec22.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) OPTION CARE HEALTH INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 68404L201 (CUSIP NUMBER) December 31, 2022 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. ROWE PRICE ASSOCIATES, INC. 52-0556948 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 604,003 6. Shared Voting Power* 0 7. Sole Dispositive Power* 2,469,612 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 2,469,612 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 1.4% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: OPTION CARE HEALTH INC Item 1(b) Address of Issuer's Principal Executive Offices: 3000 LAKESIDE DR, SUITE 300N, BANNOCKBURN, ILLINOIS 60015 Item 2(a) Name of Person(s) Filing: (1) T. ROWE PRICE ASSOCIATES, INC. (Price Associates) Item 2(b) Address of Principal Business Office: 100 E. Pratt Street, Baltimore, MD 21202 Item 2(c) Citizenship or Place of Organization: (1) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: 68404L201 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class This statement is being filed to report the fact that, as of the date of this report, the reporting person(s) has (have) ceased to be the beneficial owner of more than five percent of the class of securities. Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Associates does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Associates serves as investment adviser. Any and all discretionary authority which has been delegated to Price Associates may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Associates which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Associates. (2) With respect to securities owned by any one of the T. Rowe Price Funds, only the custodian for each of such Funds, has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. No other person is known to have such right, except that the shareholders of each such Fund participate proportionately in any dividends and distributions so paid. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. ROWE PRICE ASSOCIATES, INC. Date: February 14, 2023 Signature: /s/ David Oestreicher Name & Title: David Oestreicher, Executive Vice President 12/31/2022
    Get the next $OPCH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $OPCH

    DatePrice TargetRatingAnalyst
    4/30/2025$40.00Neutral → Buy
    UBS
    1/23/2025$26.00 → $35.00Hold → Buy
    Jefferies
    1/13/2025$26.00 → $33.00Neutral → Buy
    BofA Securities
    12/5/2024$26.00Neutral
    UBS
    11/4/2024$27.00Buy → Neutral
    Goldman
    10/31/2024$38.00 → $26.00Buy → Hold
    Jefferies
    10/30/2024$43.00 → $29.00Buy → Neutral
    BofA Securities
    7/16/2024$36.00Mkt Outperform
    JMP Securities
    More analyst ratings

    $OPCH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Option Care Health to Participate in Upcoming Investor Conferences

      BANNOCKBURN, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: The Bank of America Healthcare Conference, being held in Las Vegas, on Tuesday, May 13, 2025, including a presentation at 8:00am PT/11:00am ET.The William Blair 45th Annual Growth Stock Conference, being held in Chicago, on Tuesday, June 3, 2025, including a presentation at 11:20am CT/12:20pm ET.The Goldman Sachs 46th Annual Global Healthcare Conference, being held in Miami, on Monday, June 9, 2025, including a fireside chat

      5/1/25 4:05:00 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2025

      BANNOCKBURN, Ill., April 29, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Net revenue of $1,333.0 million, up 16.3% compared to $1,146.1 million in the first quarter of 2024Gross profit of $263.1 million, or 19.7% of net revenue, up 10.3% compared to $238.5 million, or 20.8% of net revenue, in the first quarter of 2024Net income of $46.7 million, compared to net income of $44.8 million, in the first quarter of 2024 and diluted

      4/29/25 7:00:00 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Option Care Health to Announce First Quarter 2025 Financial Results and Host Conference Call

      BANNOCKBURN, Ill., March 24, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2025 on Tuesday, April 29, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsParticipants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BI29e3b2a044544585b1ab833b09a90572. The call can also be accessed via a liv

      3/24/25 4:05:00 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care

    $OPCH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Option Care Health upgraded by UBS with a new price target

      UBS upgraded Option Care Health from Neutral to Buy and set a new price target of $40.00

      4/30/25 7:24:45 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Option Care Health upgraded by Jefferies with a new price target

      Jefferies upgraded Option Care Health from Hold to Buy and set a new price target of $35.00 from $26.00 previously

      1/23/25 7:51:53 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Option Care Health upgraded by BofA Securities with a new price target

      BofA Securities upgraded Option Care Health from Neutral to Buy and set a new price target of $33.00 from $26.00 previously

      1/13/25 12:17:48 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care

    $OPCH
    SEC Filings

    See more
    • SEC Form 10-Q filed by Option Care Health Inc.

      10-Q - Option Care Health, Inc. (0001014739) (Filer)

      4/29/25 4:00:41 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Option Care Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Option Care Health, Inc. (0001014739) (Filer)

      4/29/25 6:57:02 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • SEC Form DEFA14A filed by Option Care Health Inc.

      DEFA14A - Option Care Health, Inc. (0001014739) (Filer)

      4/2/25 4:06:47 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care

    $OPCH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Option Care Health Inc.

      SC 13G - Option Care Health, Inc. (0001014739) (Subject)

      11/8/24 10:46:38 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Option Care Health Inc. (Amendment)

      SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)

      2/13/24 5:12:03 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Option Care Health Inc. (Amendment)

      SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)

      9/11/23 1:33:44 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care

    $OPCH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Medical Officer Adewunmi Femi covered exercise/tax liability with 1,396 shares, decreasing direct ownership by 7% to 18,758 units (SEC Form 4)

      4 - Option Care Health, Inc. (0001014739) (Issuer)

      4/24/25 5:01:23 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Chief Human Resources Officer Bavaro Michael exercised 14,739 shares at a strike of $25.43 and sold $1,030,843 worth of shares (30,996 units at $33.26), decreasing direct ownership by 27% to 44,974 units (SEC Form 4)

      4 - Option Care Health, Inc. (0001014739) (Issuer)

      3/3/25 5:52:17 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Rademacher John Charles was granted 74,814 shares, increasing direct ownership by 11% to 752,181 units (SEC Form 4)

      4 - Option Care Health, Inc. (0001014739) (Issuer)

      2/26/25 7:40:41 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care

    $OPCH
    Leadership Updates

    Live Leadership Updates

    See more
    • NorthStar Medical Technologies, LLC Announces Appointment of Barbara Bodem and David Keeling to Board of Managers

      NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, today announced the appointment of Barbara W. Bodem and David Keeling to its Board of Managers, effective February 12, 2024. Following these appointments, the Board will comprise of 8 directors, 5 of whom are non-executive. "We are pleased to welcome Barbara and David to the NorthStar Board," said Stephen Merrick, Executive Chairman of NorthStar. "Barbara's deep experience serving in senior finance and board roles in leading edge pharmaceutical and

      2/27/24 9:00:00 AM ET
      $BMRN
      $ENOV
      $OPCH
      $SYNH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Industrial Specialties
      Medical/Nursing Services
    • Riverbed|Aternity Announces Appointment of New Board of Directors

      New Board Brings Significant and Diverse Experience to Support Company's Growth and Success Riverbed|Aternity (the "Company") today announced that, as part of its recapitalization, which was finalized today, the following seven directors have been appointed to the Company's new Board of Directors (the "Board"). These appointments became effective on December 7, 2021, upon the completion of the Company's recapitalization and voluntary court-supervised process. "We are pleased to welcome our new directors, a group of seasoned, accomplished and respected business leaders who will bring a wide and diverse range of skills to the Riverbed|Aternity Board," said Dan Smoot, President and CEO of Ri

      12/7/21 6:32:00 PM ET
      $MODV
      $OPCH
      Transportation Services
      Consumer Discretionary
      Medical/Nursing Services
      Health Care
    • Option Care Health Appoints Dr. Seema Kumbhat to the Position of Chief Medical Officer

      BANNOCKBURN, Ill., July 28, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health")(NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today that Dr. Seema Kumbhat has joined the Company as Chief Medical Officer. In this newly created role, Dr. Kumbhat will oversee all clinical strategies for the Company, including clinical operations, continuous quality improvement, accreditation, clinically related sales and marketing efforts, and adherence to regulatory requirements. Dr. Kumbhat will also focus on optimizing clinical operations to ensure the Company delivers the highest quality standards, supe

      7/28/21 9:00:00 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care

    $OPCH
    Financials

    Live finance-specific insights

    See more
    • Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2025

      BANNOCKBURN, Ill., April 29, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Net revenue of $1,333.0 million, up 16.3% compared to $1,146.1 million in the first quarter of 2024Gross profit of $263.1 million, or 19.7% of net revenue, up 10.3% compared to $238.5 million, or 20.8% of net revenue, in the first quarter of 2024Net income of $46.7 million, compared to net income of $44.8 million, in the first quarter of 2024 and diluted

      4/29/25 7:00:00 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Option Care Health to Announce First Quarter 2025 Financial Results and Host Conference Call

      BANNOCKBURN, Ill., March 24, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2025 on Tuesday, April 29, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsParticipants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BI29e3b2a044544585b1ab833b09a90572. The call can also be accessed via a liv

      3/24/25 4:05:00 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2024

      BANNOCKBURN, Ill., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights Net revenue of $1,346.4 million, up 19.7% compared to $1,124.4 million in the fourth quarter of 2023Gross profit of $268.4 million, or 19.9% of net revenue, up 8.6% compared to $247.1 million, or 22.0% of net revenue, in the fourth quarter of 2023Net income of $60.1 million, compared to net income of $57.2 million, in the fourth quarter

      2/26/25 7:00:00 AM ET
      $OPCH
      Medical/Nursing Services
      Health Care

    $OPCH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Kraemer Harry M Jansen Jr bought $969,031 worth of shares (43,000 units at $22.54), increasing direct ownership by 15% to 326,334 units (SEC Form 4)

      4 - Option Care Health, Inc. (0001014739) (Issuer)

      11/13/24 5:27:03 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Kraemer Harry M Jansen Jr bought $1,104,352 worth of shares (35,000 units at $31.55), increasing direct ownership by 15% to 269,528 units (SEC Form 4)

      4 - Option Care Health, Inc. (0001014739) (Issuer)

      2/28/24 4:41:59 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care
    • Bierbower Elizabeth D bought $79,110 worth of shares (3,000 units at $26.37), increasing direct ownership by 29% to 13,515 units (SEC Form 4)

      4 - Option Care Health, Inc. (0001014739) (Issuer)

      11/1/23 5:09:51 PM ET
      $OPCH
      Medical/Nursing Services
      Health Care